These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

683 related articles for article (PubMed ID: 33052226)

  • 1. Perspectives on how mucosal immune responses, infections and gut microbiome shape IgA nephropathy and future therapies.
    He JW; Zhou XJ; Lv JC; Zhang H
    Theranostics; 2020; 10(25):11462-11478. PubMed ID: 33052226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy.
    Fan Y; Wang Y; Xiao H; Sun H
    BMC Nephrol; 2024 Jun; 25(1):203. PubMed ID: 38907188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA production and tonsillar focal infection in IgA nephropathy.
    Meng H; Ohtake H; Ishida A; Ohta N; Kakehata S; Yamakawa M
    J Clin Exp Hematop; 2012; 52(3):161-70. PubMed ID: 23269075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of gut-homing immunoglobulin A+ B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients.
    Sallustio F; Curci C; Chaoul N; Fontò G; Lauriero G; Picerno A; Divella C; Di Leo V; De Angelis M; Ben Mkaddem S; Macchia L; Gallone A; Monteiro RC; Pesce F; Gesualdo L
    Nephrol Dial Transplant; 2021 Feb; 36(3):452-464. PubMed ID: 33200215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Gut-Renal Connection in IgA Nephropathy.
    Coppo R
    Semin Nephrol; 2018 Sep; 38(5):504-512. PubMed ID: 30177022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of IgAN.
    Barratt J; Smith AC; Molyneux K; Feehally J
    Semin Immunopathol; 2007 Nov; 29(4):427-43. PubMed ID: 17851660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenetic and Therapeutic Role of Gut Microbiome in Immunoglobin A Nephropathy.
    Li HB; Zhou JL; Xie PP; Feng YT; Chen Y; Zhang DF; Wang DG; Pan HF
    Curr Pharm Des; 2023; 29(6):468-473. PubMed ID: 36825697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microbiome and IgA nephropathy.
    Haniuda K; Gommerman JL; Reich HN
    Semin Immunopathol; 2021 Oct; 43(5):649-656. PubMed ID: 34664087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of complement in IgA nephropathy.
    Daha MR; van Kooten C
    J Nephrol; 2016 Feb; 29(1):1-4. PubMed ID: 26567162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J; Moldoveanu Z; Julian BA; Raska M; Wyatt RJ; Suzuki Y; Tomino Y; Gharavi AG; Mestecky J; Suzuki H
    Adv Otorhinolaryngol; 2011; 72():60-3. PubMed ID: 21865691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune responses primed by the alteration of gut microbiota were associated with galactose-deficient IgA1 production in IgA nephropathy.
    Gao L; Li H; Liu X; Li H; Li P; Lu W; Xie X; Lv J; Jin J
    Front Immunol; 2024; 15():1415026. PubMed ID: 39104521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal targeting in IgA nephropathy targeting the gut associated lymphoid tissue.
    Barratt J
    Nephrology (Carlton); 2024 Sep; 29 Suppl 2():34-36. PubMed ID: 39327765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population.
    Zhong Z; Tan J; Tan L; Tang Y; Qiu Z; Pei G; Qin W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107085. PubMed ID: 33068859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of complement in IgA nephropathy.
    Tortajada A; Gutierrez E; Pickering MC; Praga Terente M; Medjeral-Thomas N
    Mol Immunol; 2019 Oct; 114():123-132. PubMed ID: 31351413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status.
    Jessen RH; Emancipator SN; Jacobs GH; Nedrud JG
    Lab Invest; 1992 Sep; 67(3):379-86. PubMed ID: 1328763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mucosal immune system and IgA nephropathy.
    Gesualdo L; Di Leo V; Coppo R
    Semin Immunopathol; 2021 Oct; 43(5):657-668. PubMed ID: 34642783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgA Nephropathy: Core Curriculum 2021.
    Pattrapornpisut P; Avila-Casado C; Reich HN
    Am J Kidney Dis; 2021 Sep; 78(3):429-441. PubMed ID: 34247883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental nephropathy induced by Haemophilus parainfluenzae antigens.
    Yamamoto C; Suzuki S; Kimura H; Yoshida H; Gejyo F
    Nephron; 2002 Mar; 90(3):320-7. PubMed ID: 11867953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haemophilus parainfluenzae antigens in IgA nephropathy].
    Suzuki S; Kimura H; Gejyo F
    Rinsho Byori; 1998 Jan; 46(1):17-25. PubMed ID: 9492534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic IgA in IgA nephropathy: still the blind men and the elephant?
    Lai KN
    Kidney Int; 2006 Apr; 69(7):1102-3. PubMed ID: 16609676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.